SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

Registration Statements
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
EFFECT

EFFECT

Other
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML

Data provided by Kaleidoscope.